These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27702846)

  • 1. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor psychiatric disorders and syncope: the role of psychopathology in the expression of vasovagal reflex.
    Leftheriotis D; Michopoulos I; Flevari P; Douzenis A; Koborozos C; Kostopoulou A; Theodorakis GN; Lykouras L; Kremastinos DT
    Psychother Psychosom; 2008; 77(6):372-6. PubMed ID: 18716422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope.
    D'Antono B; Dupuis G; St-Jean K; Lévesque K; Nadeau R; Guerra P; Thibault B; Kus T
    J Psychosom Res; 2009 Sep; 67(3):213-22. PubMed ID: 19686877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
    Flevari P; Livanis EG; Theodorakis GN; Zarvalis E; Mesiskli T; Kremastinos DT
    J Am Coll Cardiol; 2002 Aug; 40(3):499-504. PubMed ID: 12142117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
    Gracie J; Newton JL; Norton M; Baker C; Freeston M
    Europace; 2006 Aug; 8(8):636-43. PubMed ID: 16864617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperament and character personality dimensions in nitrate-tilt-induced vasovagal syncope patients.
    Russo V; AlTurki A; Rago A; Proietti R; Chaussé G; Monteleone AM; Scognamiglio P; Monteleone P; Nigro G
    Hellenic J Cardiol; 2017; 58(6):411-416. PubMed ID: 28212873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Situational syncope: response to head-up tilt testing and follow-up: comparison with vasovagal syncope.
    Livanis EG; Leftheriotis D; Theodorakis GN; Flevari P; Zarvalis E; Kolokathis F; Kremastinos DT
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):918-23. PubMed ID: 15271010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflex syncope, anxiety level, and family history of cardiovascular disease in young women: case-control study.
    Zyśko D; Szewczuk-Bogusławska M; Kaczmarek M; Agrawal AK; Rudnicki J; Gajek J; Melander O; Sutton R; Fedorowski A
    Europace; 2015 Feb; 17(2):309-13. PubMed ID: 25179650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic prevention of recurrent vasovagal syncope: A systematic review and network meta-analysis of randomized controlled trials.
    Behnoush AH; Yazdani K; Khalaji A; Tavolinejad H; Aminorroaya A; Jalali A; Tajdini M
    Heart Rhythm; 2023 Mar; 20(3):448-460. PubMed ID: 36509319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Heart Rhythm; 2020 Jul; 17(7):1151-1158. PubMed ID: 32151742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5).
    Raj SR; Faris PD; Semeniuk L; Manns B; Krahn AD; Morillo CA; Benditt DG; Sheldon RS;
    Am Heart J; 2016 Apr; 174():89-94. PubMed ID: 26995374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals.
    Ng J; Sheldon RS; Ritchie D; Raj V; Raj SR
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):180-188. PubMed ID: 30488466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate recovery and diastolic blood pressure ratio on the treadmill test predict an induction and recurrence of vasovagal syncope.
    Choi YJ; Kang KW; Jang SH; Kim JG; Lee SJ; Jung KT
    Korean J Intern Med; 2019 Mar; 34(2):315-323. PubMed ID: 29240992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the recurrent syncope episodes on neurocognitive functions in patients with vasovagal syncope.
    Jędrzejczyk-Spaho J; Pietrucha AZ; Borowiec A; Bzukała I; Wnuk M; Konduracka E; Nessler J
    Pol Merkur Lekarski; 2017 Mar; 42(249):106-109. PubMed ID: 28333901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI.
    Sheldon RS; Lei L; Guzman JC; Kus T; Ayala-Paredes FA; Angihan J; Safdar S; Maxey C; Bennett G; Raj SR
    Europace; 2019 Nov; 21(11):1733-1741. PubMed ID: 31538180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.